fr

Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

Financial agenda 2013

Download

Recent participations in two scientific conferences

Download

2012 half-year results

Download

CARMAT publishes its second Shareholder Newsletter

Download

Further elements added to the ANSM file

Download

CARMAT wins the Best technology category at the European Mediscience Awards

Download

FYR 2011: a sound cash position of €29.4m at 31.12.2011

Download

CARMAT publishes its first Shareholder Newsletter

Download
Top of page